Lungemedicinsk og endokrinologisk Afdeling

Medicin og biovidenskab

1. Chronic Obstructive Pulmonary Disease 100%
2. Asthma 44%
3. Insulin 40%
4. Glucose 40%
5. Type 2 Diabetes Mellitus 40%
6. Type 1 Diabetes Mellitus 32%
7. Gastric Bypass 32%
8. Glucagon-Like Peptide 1 31%
9. Liraglutide 25%
10. Placebos 21%
11. Denmark 20%
12. Weight Loss 19%
13. Randomized Controlled Trials 19%
14. Hypoglycemia 19%
15. Lung 19%
16. Glucagon-Like Peptide-1 Receptor 17%
17. Therapeutics 17%
18. Insulin Resistance 16%
19. Mortality 16%
20. Glucagon 16%
21. Obesity 16%
22. Adrenal Cortex Hormones 16%
23. Population 14%
24. Cohort Studies 13%
25. Incretins 13%
26. Meals 11%
27. Hormones 10%
28. Systematic Reviews 10%
29. Fasting 9%
30. Bone Density 9%
31. Metformin 9%
32. Smoking 9%
33. Smokers 9%
34. Osteoporosis 9%
35. Carbohydrates 9%
36. Forced Expiratory Volume 9%
37. Insulin Secretion 8%
38. Coronavirus 8%
39. Weights and Measures 8%
40. Peptides 8%
41. Hospitalization 8%
42. Cross-Over Studies 8%
43. Rehabilitation 8%
44. Biomarkers 8%
45. Confidence Intervals 8%
46. Fats 7%
47. Body Mass Index 7%
48. Bariatric Surgery 7%
49. Quality of Life 7%
50. Prospective Studies 7%
51. Exercise 7%
52. Skeletal Muscle 7%
53. Dyspnea 7%
54. Bone and Bones 7%
55. Spirometry 6%
56. Oxygen 6%
57. Bronchodilator Agents 6%
58. Blood Pressure 6%
59. Cardiovascular Diseases 6%
60. Safety 5%
61. Diet 5%
62. Guidelines 5%
63. Disease Progression 5%
64. Hip Fractures 5%
65. Blood Glucose 5%
66. Maintenance 5%
67. High-Protein Diet 5%
68. Meta-Analysis 5%
69. Outpatients 5%
70. Liver 5%
71. Observational Studies 5%
72. Body Composition 5%
73. Triglycerides 5%
74. Heart 5%
75. C-Peptide 5%
76. Pregnancy 5%
77. HIV 5%
78. Phenotype 5%
79. Inflammation 5%
80. Registries 5%
81. semaglutide 5%